Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Ascending-Dose, Single-Centre Study Investigating the Safety, Tolerability, Efficacy, and Pharmacokinetics of VR040(Inhaled Apomorphine)in Parkinson's Disease

NCT01683292 is registered in ClinicalTrials.gov with South Glasgow University Hospitals NHS Trust as lead sponsor.

NCT NCT01683292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01683292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Ascending-Dose, Single-Centre Study Investigating the Safety, Tolerability, Efficacy, and Pharmacokinetics of VR040(Inhaled Apomorphine)in Parkinson's Disease
Lead sponsor
South Glasgow University Hospitals NHS Trust
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
May 31, 2007
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease